MedTrace Logo

Project ICOPE Brazil: Assessment of Intrinsic Capacity in Brazilian Older Adults

NCT06968702 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3838

Last updated 2025-05-13

No results posted yet for this study

Summary

The ICOPE Brazil study aims to understand aging trajectories in Brazil, especially healthy aging trends based on intrinsic capacity, a collective of mental and physical capacities one may have to maintain their functional ability to execute daily life activities. Tests and questionnaires will be applied to collect data on mobility capacity, cognitive capacity, nutritional status, vision, and hearing (sensorial) capacities, and mental health. These assessments are in consonance with what the World Health Organization proposed in the Integrated Care for Older People Program (ICOPE). Participants will be followed up for three years, and the primary outcomes of interest are loss of intrinsic capacity, mobility impairment, cognitive impairment, incident depressive symptoms, loss of functional ability, incident frailty, incident sarcopenia, incident falls, hospitalization, multimorbidity, and mortality.

Conditions

  • Intrinsic Capacity
  • Frailty
  • Aging
  • Healthy Aging
  • Functional Ability
  • Mobility and Independence
  • Cognitive Ability, General
  • Cognitive Impairment
  • Sensory Hearing Loss
  • Sensory Deficits
  • Visual Acuity
  • Visual Impairment
  • Mood Disorders
  • Depressive Symptoms
  • Vitality
  • Nutritional Risk
  • Nutrition Assessment

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Eduardo Ferriolli, MD, MSc, PhD · University of Sao Paulo

  • Renato Bandeira de Mello, MD, MPH, PhD · Federal University of Rio Grande do Sul

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-15
Primary Completion
2028-11-30
Completion
2029-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06968702 on ClinicalTrials.gov